【発明の名称】新規カルシウムチャンネル薬物および用途

Title:

【発明の名称】新規カルシウムチャンネル薬物および用途

Document Type and Number:

Japanese Patent JP2002517440

Kind Code:

A

Abstract:

Novel multibinding compounds are disclosed. The compounds of this invention comprise 2 - 10 ligands covalently connected, each of the ligands being capable of binding to a ligand binding site in a Ca<++> channel, thereby modulating the biological activities thereof.

More Like This:

WO/2003/105757	METHODS AND COMPOSITIONS FOR MILIEU-DEPENDENT BINDING OF A TARGETED AGENT TO A TARGET
JP2023532378	Fluorescent cross-linking RNase H mutant conjugates, miRNA combinations and uses thereof
WO/2000/014537	IMMUNOCONJUGATE FOR DIAGNOSIS OF MULTIDRUG RESISTANCE

Inventors:

The, You Hua
Natarajan, Maya
Griffin, John H.

Application Number:

JP2000553061A

Publication Date:

June 18, 2002

Filing Date:

June 07, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Advanced Medicine Incorporated

International Classes:

G01N33/53; A61K31/277; A61K31/4422; A61K31/554; A61K39/395; A61K47/48; A61P9/00; A61P43/00; C07C255/43; C07D211/90; C07D281/10; C07D417/12; C07D417/14; G01N33/543; G01N33/566; G01N33/68; (IPC1-7): C07C255/43; A61K31/277; A61K31/4422; A61K31/554; A61K39/395; A61K47/48; A61P9/00; A61P43/00; C07D211/90; C07D281/10; C07D417/12; C07D417/14; G01N33/53; G01N33/543; G01N33/566

Attorney, Agent or Firm:

Shusaku Yamamoto

Previous Patent: Ｎ−アセチル３−クロロプロカインアミド、それらの酸付加塩、および使�...

Next Patent: ＨＩＶプロテアーゼ阻害性化合物の新規使用